Back
Eagle Pharmaceuticals Vs. Transcat Industry Stock Comparison
Sell
36
EGRX
Eagle Pharmaceuticals
Last Price:
3.83
Seasonality Move:
-2.11%
Buy
62
TRNS
Transcat
Last Price:
121.40
Seasonality Move:
5.39%
Sell
36
Eagle Pharmaceuticals (EGRX)
is a Sell
Is Eagle Pharmaceuticals a Buy, Sell or Hold?
- The current Eagle Pharmaceuticals [EGRX] share price is $3.85. The Score for EGRX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- EGRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Transcat (TRNS)
is a Buy
Is Transcat a Buy, Sell or Hold?
- The current Transcat [TRNS] share price is $121.59. The Score for TRNS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- TRNS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EGRX Stock Price Chart
What is Eagle Pharmaceuticals's stock price today?
-
The Eagle Pharmaceuticals share price today is $3.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EGRX is experiencing slight buying pressure.
TRNS Stock Price Chart
EGRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 47.21 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.54 - 4.44) | Sell |
| Bollinger Bands (100): | (4.12 - 5.82) | Sell |
TRNS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.19 | Buy |
| Relative Strength Index (14 RSI): | 45.27 | Sell |
| Chaikin Money Flow: | 11200 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.29 - 133.09) | Sell |
| Bollinger Bands (100): | (104.3 - 122.26) | Buy |
EGRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.75 | Buy |
| 20-day SMA: | 3.83 | Buy |
| 50-day SMA: | 4.29 | Sell |
| 200-day SMA: | 7.73 | Sell |
| 8-day EMA: | 3.75 | Buy |
| 20-day EMA: | 3.87 | Sell |
| 50-day EMA: | 4.29 | Sell |
| 200-day EMA: | 8.59 | Sell |
TRNS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.83 | Sell |
| 20-day SMA: | 128.56 | Sell |
| 50-day SMA: | 118.56 | Buy |
| 200-day SMA: | 106.03 | Buy |
| 8-day EMA: | 124.88 | Sell |
| 20-day EMA: | 125.15 | Sell |
| 50-day EMA: | 120.46 | Buy |
| 200-day EMA: | 107.38 | Buy |
Eagle Pharmaceuticals Earnings Growth & EGRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.00 per share.
Transcat Earnings Growth & TRNS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.27 per share, an increase this year of $0.68 per share, and an increase next year of $0.59 per share.
Eagle Pharmaceuticals Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Transcat Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||